Clinical Trial Update: Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis [EARLY_Phase 1]

View source ↗

Summary

A clinical trial update for an early-phase (Phase 1) study evaluating human amniotic-derived mesenchymal stem cell therapy for calciphylaxis in chronic kidney d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Calciphylaxis
• Chronic Kidney Disease

Drugs mentioned

• Human Amniotic-Derived Mesenchymal Stem Cell Therapy (human amniotic-derived mesenchymal stem cells)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Chronic Kidney Diseases, Calciphylaxis | EARLY_Phase 1 | Status: RECRUITING